No black box warning on record for Eucrisa

As of the latest FDA labeling reviewed, Eucrisa (CRISABOROLE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Eucrisa medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypersensitivity reactions : If signs and symptoms of hypersensitivity occur, discontinue EUCRISA immediately and initiate appropriate therapy. ( 5.1 ) 5.1 Hypersensitivity Reactions Hypersensitivity reactions, including contact urticaria, have occurred in patients treated with EUCRISA. Hypersensitivity should be suspected in the event of severe pruritus, swelling and er

No black box warning on record for Eucrisa

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypersensitivity reactions : If signs and symptoms of hypersensitivity occur, discontinue EUCRISA immediately and initiate appropriate therapy. ( 5.1 ) 5.1 Hypersensitivity Reactions Hypersensitivity reactions, including contact urticaria, have occurred in patients treated with EUCRISA. Hypersensitivity should be suspected in the event of severe pruritus, swelling and er

Eucrisa Black Box Warning

No black box warning on record for Eucrisa

Other warnings & precautions

Eucrisa Black Box Warning

No black box warning on record for Eucrisa

Other warnings & precautions